Chinese Journal of Dermatology ›› 2024, Vol. 57 ›› Issue (3): 201-208.doi: 10.35541/cjd.20230711
• Guidelines and Consensus • Previous Articles Next Articles
Hospital for Skin Diseases, Chinese Academy of Medical Sciences; National Center for STD Control, Chinese Center for Disease Control and Prevention; Venereology Group, Chinese Society of Dermatology; Chinese Association Rehabilitation of Dermatology
Received:
2023-12-04
Revised:
2024-01-08
Online:
2024-03-15
Published:
2024-03-04
Contact:
Su Xiaohong; Wang Qianqiu; Liu Quanzhong
E-mail:suxh@ncstdlc.org; wangqq@ncstdlc.org; liuquanzhong@tmu.edu.cn
Supported by:
Hospital for Skin Diseases, Chinese Academy of Medical Sciences, National Center for STD Control, Chinese Center for Disease Control and Prevention, Venereology Group, Chinese Society of Dermatology, Chinese Association Rehabilitation of Dermatology . Chinese expert consensus on the diagnosis and treatment of Mycoplasma genitalium infection (2024)[J]. Chinese Journal of Dermatology, 2024, 57(3): 201-208.doi:10.35541/cjd.20230711
[1] | Taylor⁃Robinson D, Jensen JS. Mycoplasma genitalium: from chrysalis to multicolored butterfly[J]. Clin Microbiol Rev, 2011,24(3):498⁃514. doi: 10.1128/CMR.00006⁃11. |
[2] | Horner PJ, Martin DH. Mycoplasma genitalium infection in men[J]. J Infect Dis, 2017,216(suppl_2):S396⁃S405. doi: 10.1093/infdis/jix145. |
[3] | Lis R, Rowhani⁃Rahbar A, Manhart LE. Mycoplasma genitalium infection and female reproductive tract disease: a meta⁃analysis[J]. Clin Infect Dis, 2015,61(3):418⁃426. doi: 10.1093/cid/civ312. |
[4] | Barker EK, Malekinejad M, Merai R, et al. Risk of human immunodeficiency virus acquisition among high⁃risk hetero⁃sexuals with nonviral sexually transmitted infections: a systematic review and meta⁃analysis[J]. Sex Transm Dis, 2022,49(6):383⁃397. doi: 10.1097/OLQ.0000000000001601. |
[5] | Manhart LE, Mostad SB, Baeten JM, et al. High Mycoplasma genitalium organism burden is associated with shedding of HIV⁃1 DNA from the cervix[J]. J Infect Dis, 2008,197(5):733⁃736. doi: 10.1086/526501. |
[6] | US Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019[EB]. Atlanta: Department of Health and Human Services, 2019. |
[7] | Jensen JS, Cusini M, Gomberg M, et al. 2016 European guideline on Mycoplasma genitalium infections[J]. J Eur Acad Dermatol Venereol, 2016,30(10):1650⁃1656. doi: 10.1111/jdv.13849. |
[8] | Jensen JS, Cusini M, Gomberg M, et al. 2021 European guideline on the management of Mycoplasma genitalium infections[J]. J Eur Acad Dermatol Venereol, 2022,36(5):641⁃650. doi: 10. 1111/jdv.17972. |
[9] | 王千秋, 刘全忠, 徐金华, 等. 性传播疾病临床诊疗与防治指南[M]. 2版. 上海: 上海科学技术出版社, 2020. |
[10] | Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations[J]. BMJ, 2008,336(7650):924⁃926. doi: 10. 1136/bmj.39489.470347.AD. |
[11] | Dehon PM, McGowin CL. The immunopathogenesis of Mycoplasma genitalium infections in women: a narrative review[J]. Sex Transm Dis, 2017,44(7):428⁃432. doi: 10.1097/OLQ. 0000000000000621. |
[12] | Fraser CM, Gocayne JD, White O, et al. The minimal gene complement of Mycoplasma genitalium[J]. Science, 1995,270(5235):397⁃403. doi: 10.1126/science.270.5235.397. |
[13] | Burgos R, Pich OQ, Ferrer⁃Navarro M, et al. Mycoplasma genitalium P140 and P110 cytadhesins are reciprocally stabilized and required for cell adhesion and terminal⁃organelle development[J]. J Bacteriol, 2006,188(24):8627⁃8637. doi: 10. 1128/JB.00978⁃06. |
[14] | Li L, Krishnan M, Baseman JB, et al. Molecular cloning, expression, and characterization of a Ca2+⁃dependent, membrane⁃associated nuclease of Mycoplasma genitalium[J]. J Bacteriol, 2010,192(19):4876⁃4884. doi: 10.1128/JB.00401⁃10. |
[15] | Christodoulides A, Gupta N, Yacoubian V, et al. The role of lipoproteins in Mycoplasma⁃mediated immunomodulation[J]. Front Microbiol, 2018,9:1682. doi: 10.3389/fmicb.2018.01682. |
[16] | Burgos R, Wood GE, Iverson⁃Cabral SL, et al. Mycoplasma genitalium nonadherent phase variants arise by multiple mechanisms and escape antibody⁃dependent growth inhibition[J]. Infect Immun, 2018,86(4). doi: 10.1128/IAI.00866⁃17. |
[17] | Arfi Y, Minder L, Di Primo C, et al. MIB⁃MIP is a mycoplasma system that captures and cleaves immunoglobulin G[J]. Proc Natl Acad Sci U S A, 2016,113(19):5406⁃5411. doi: 10.1073/pnas.1600546113. |
[18] | McAuliffe L, Ellis RJ, Miles K, et al. Biofilm formation by mycoplasma species and its role in environmental persistence and survival[J]. Microbiology (Reading), 2006,152(Pt 4):913⁃922. doi: 10.1099/mic.0.28604⁃0. |
[19] | Li Y, Su X, Le W, et al. Mycoplasma genitalium in symptomatic male urethritis: macrolide use is associated with increased resistance[J]. Clin Infect Dis, 2020,70(5):805⁃810. doi: 10. 1093/cid/ciz294. |
[20] | Shipitsyna E, Kularatne R, Golparian D, et al. Mycoplasma genitalium prevalence, antimicrobial resistance⁃associated mutations, and coinfections with non⁃viral sexually transmitted infections in high⁃risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019 -2021[J]. Front Microbiol, 2023,14:1130762. doi: 10.3389/fmicb.2023.1130762. |
[21] | Aboud S, Buhalata SN, Onduru OG, et al. High prevalence of Sexually Transmitted and Reproductive Tract Infections (STI/RTIs) among patients attending STI/Outpatient department clinics in Tanzania[J]. Trop Med Infect Dis, 2023,8(1). doi: 10.3390/tropicalmed8010062. |
[22] | Baumann L, Cina M, Egli⁃Gany D, et al. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta⁃analysis[J]. Sex Transm Infect, 2018,94(4):255⁃262. doi: 10.1136/sextrans⁃2017⁃053384. |
[23] | 宣岩, 魏兰馨, 洪翔, 等. 我国不同人群生殖支原体感染率的Meta分析[J]. 中华流行病学杂志, 2021,42(2):335⁃342. doi: 10.3760/cma.j.cn112338⁃20200530⁃00791. |
[24] | Cina M, Baumann L, Egli⁃Gany D, et al. Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta⁃analysis[J]. Sex Transm Infect, 2019,95(5):328⁃335. doi: 10.1136/sextrans⁃2018⁃053823. |
[25] | Balkus JE, Manhart LE, Jensen JS, et al. Mycoplasma genitalium infection in Kenyan and US Women[J]. Sex Transm Dis, 2018,45(8):514⁃521. doi: 10.1097/OLQ.0000000000000799. |
[26] | Latimer RL, Vodstrcil L, De Petra V, et al. Extragenital Mycoplasma genitalium infections among men who have sex with men[J]. Sex Transm Infect, 2020,96(1):10⁃18. doi: 10.1136/sextrans⁃2019⁃054058. |
[27] | Sonnenberg P, Ison CA, Clifton S, et al. Epidemiology of Mycoplasma genitalium in British men and women aged 16 - 44 years: evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal⁃3)[J]. Int J Epidemiol, 2015,44(6):1982⁃1994. doi: 10.1093/ije/dyv194. |
[28] | Bissessor M, Tabrizi SN, Bradshaw CS, et al. The contribution of Mycoplasma genitalium to the aetiology of sexually acquired infectious proctitis in men who have sex with men[J]. Clin Microbiol Infect, 2016,22(3):260⁃265. doi: 10.1016/j.cmi.2015. 11.016. |
[29] | Francis SC, Kent CK, Klausner JD, et al. Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005 -2006[J]. Sex Transm Dis, 2008,35(9):797⁃800. doi: 10.1097/OLQ.0b013e 318177ec39. |
[30] | Ong JJ, Aung E, Read T, et al. Clinical characteristics of anorectal Mycoplasma genitalium infection and microbial cure in men who have sex with men[J]. Sex Transm Dis, 2018,45(8):522⁃526. doi: 10.1097/OLQ.0000000000000793. |
[31] | Ito S, Tsuchiya T, Yasuda M, et al. Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years⁃of⁃age with acute epididymitis[J]. Int J Urol, 2012,19(3):234⁃238. doi: 10.1111/j.1442⁃2042.2011.02917.x. |
[32] | Krieger JN, Riley DE, Roberts MC, et al. Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis[J]. J Clin Microbiol, 1996,34(12):3120⁃3128. doi: 10.1128/jcm.34.12. 3120⁃3128.1996. |
[33] | Mo X, Zhu C, Gan J, et al. Prevalence and correlates of Mycoplasma genitalium infection among prostatitis patients in Shanghai, China[J]. Sex Health, 2016,doi: 10.1071/SH15155. |
[34] | Ahmadi MH, Mirsalehian A, Gilani M, et al. Improvement of semen parameters after antibiotic therapy in asymptomatic infertile men infected with Mycoplasma genitalium[J]. Infection, 2018,46(1):31⁃38. doi: 10.1007/s15010⁃017⁃1075⁃3. |
[35] | Huang C, Zhu HL, Xu KR, et al. Mycoplasma and ureaplasma infection and male infertility: a systematic review and meta⁃analysis[J]. Andrology, 2015,3(5):809⁃816. doi: 10.1111/andr. 12078. |
[36] | Olson E, Gupta K, Van Der Pol B, et al. Mycoplasma genitalium infection in women reporting dysuria: a pilot study and review of the literature[J]. Int J STD AIDS, 2021,32(13):1196⁃1203. doi: 10.1177/09564624211030040. |
[37] | Lewis J, Horner PJ, White PJ. Incidence of pelvic inflammatory disease associated with Mycoplasma genitalium infection: evidence synthesis of cohort study data[J]. Clin Infect Dis, 2020,71(10):2719⁃2722. doi: 10.1093/cid/ciaa419. |
[38] | Latimer RL, Read T, Vodstrcil LA, et al. Clinical features and therapeutic response in women meeting criteria for presumptive treatment for pelvic inflammatory disease associated with Mycoplasma genitalium[J]. Sex Transm Dis, 2019,46(2):73⁃79. doi: 10.1097/OLQ.0000000000000924. |
[39] | Frenzer C, Egli⁃Gany D, Vallely LM, et al. Adverse pregnancy and perinatal outcomes associated with Mycoplasma genitalium: systematic review and meta⁃analysis[J]. Sex Transm Infect, 2022,98(3):222⁃227. doi: 10.1136/sextrans⁃2021⁃055352. |
[40] | Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021[J]. MMWR Recomm Rep, 2021,70(4):1⁃187. doi: 10.15585/mmwr.rr7004a1. |
[41] | The Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Australian STI management guidelines for use in primary care[EB/OL]. [2023⁃07⁃20]. https://sti.guidelines.org.au/sexually⁃transmissible⁃infections/mycoplasma⁃genitalium/. |
[42] | Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018)[J]. Int J STD AIDS, 2019,30(10):938⁃950. doi: 10.1177/0956462419825948. |
[43] | Jensen JS, Björnelius E, Dohn B, et al. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic[J]. Sex Transm Dis, 2004,31(8):499⁃507. doi: 10.1097/01.olq.0000135992.98883.e4. |
[44] | Gaydos CA, Manhart LE, Taylor SN, et al. Molecular testing for Mycoplasma genitalium in the United States: results from the AMES prospective multicenter clinical study[J]. J Clin Microbiol, 2019,57(11):e01125⁃01119. doi: 10.1128/JCM.01125⁃19. |
[45] | Peris MP, Dehesa B, Alonso H, et al. Retrospective and comparative study of three molecular assays for the macrolide resistance detection in Mycoplasma genitalium positive urogenital specimens[J]. Int J Mol Sci, 2023,24(8):7218. doi: 10.3390/ijms24087218. |
[46] | Fernández⁃Huerta M, Bodiyabadu K, Esperalba J, et al. Multicenter clinical evaluation of a novel multiplex real⁃time PCR (qPCR) assay for detection of fluoroquinolone resistance in Mycoplasma genitalium[J]. J Clin Microbiol, 2019,57(11):e00886⁃19. doi: 10.1128/JCM.00886⁃19. |
[47] | Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment[J]. J Infect Dis, 2017,216(suppl_2):S412⁃S419. doi: 10.1093/infdis/jix132. |
[48] | Abavisani M, Keikha M. Global analysis on the mutations associated with multidrug⁃resistant urogenital mycoplasmas and ureaplasmas infection: a systematic review and meta⁃analysis[J]. Ann Clin Microbiol Antimicrob, 2023,22(1):70. doi: 10. 1186/s12941⁃023⁃00627⁃6. |
[49] | Ke W, Li D, Tso LS, et al. Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016 -2018[J]. BMC Infect Dis, 2020,20(1):950. doi: 10.1186/s12879⁃020⁃05659⁃3. |
[50] | Wang L, Li Z, Wan C, et al. Prevalence of Mycoplasma genitalium infection with antimicrobial resistance mutations among gay sex workers in China[J]. Int J STD AIDS, 2023,34(8):518⁃524. doi: 10.1177/09564624231160676. |
[51] | Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium⁃infected cohort and response of azithromycin failures to alternative antibiotic regimens[J]. Clin Infect Dis, 2015,60(8):1228⁃1236. doi: 10.1093/cid/ciu1162. |
[52] | Murray GL, Bodiyabadu K, Vodstrcil LA, et al. parC Variants in Mycoplasma genitalium: trends over time and association with moxifloxacin failure[J]. Antimicrob Agents Chemother, 2022,66(5):e0027822. doi: 10.1128/aac.00278⁃22. |
[53] | Murray GL, Bodiyabadu K, Danielewski J, et al. Moxifloxacin and sitafloxacin treatment failure in Mycoplasma genitalium infection: association with parC mutation G248T (S83I) and concurrent gyrA mutations[J]. J Infect Dis, 2020,221(6):1017⁃1024. doi: 10.1093/infdis/jiz550. |
[54] | 袁梦瑾. MG感染耐药性和治疗的研究[D]. 北京: 北京协和医学院, 2023. |
[55] | Read T, Fairley CK, Murray GL, et al. Outcomes of resistance⁃guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation[J]. Clin Infect Dis, 2019,68(4):554⁃560. doi: 10.1093/cid/ciy477. |
[56] | Durukan D, Read T, Murray G, et al. Resistance⁃guided antimicrobial therapy using doxycycline⁃moxifloxacin and doxycycline⁃2.5 g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability[J]. Clin Infect Dis, 2020,71(6):1461⁃1468. doi: 10.1093/cid/ciz1031. |
[57] | Durukan D, Doyle M, Murray G, et al. Doxycycline and sitafloxacin combination therapy for treating highly resistant Mycoplasma genitalium[J]. Emerg Infect Dis, 2020,26(8):1870⁃1874. doi: 10.3201/eid2608.191806. |
[58] | 李赛, 薛华忠, 张树文, 等. 多西环素⁃莫西沙星序贯疗法治疗生殖支原体尿道炎/宫颈炎的临床观察[J]. 中华皮肤科杂志, 2022,55(12):1092⁃1095. doi: 10.35541/cjd.20210631. |
[59] | Li L, Yuan Y, He W, et al. Emerging multidrug resistance contributes to treatment failure in Mycoplasma genitalium infected patients in China[J]. Diagn Microbiol Infect Dis, 2023,105(2):115854. doi: 10.1016/j.diagmicrobio.2022.115854. |
[60] | Ando N, Mizushima D, Takano M, et al. Effectiveness of sitafloxacin monotherapy for quinolone⁃resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study[J]. J Antimicrob Chemother, 2023,78(8):2070⁃2079. doi: 10.1093/jac/dkad208. |
[61] | Doyle M, Vodstrcil LA, Plummer EL, et al. Nonquinolone options for the treatment of Mycoplasma genitalium in the era of increased resistance[J]. Open Forum Infect Dis, 2020,7(8):ofaa291. doi: 10.1093/ofid/ofaa291. |
[62] | Clarke EJ, Vodstrcil LA, Plummer EL, et al. Efficacy of minocycline for the treatment of Mycoplasma genitalium[J]. Open Forum Infect Dis, 2023,10(8):ofad427. doi: 10.1093/ofid/ofad427. |
[63] | Glaser AM, Geisler WM, Ratliff AE, et al. Two cases of multidrug⁃resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline[J]. Int J STD AIDS, 2019,30(5):512⁃514. doi: 10.1177/0956462418816757. |
[64] | Read T, Jensen JS, Fairley CK, et al. Use of pristinamycin for macrolide⁃resistant Mycoplasma genitalium infection[J]. Emerg Infect Dis, 2018,24(2):328⁃335. doi: 10.3201/eid2402.170902. |
[65] | Falk L, Enger M, Jensen JS. Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women[J]. J Antimicrob Chemother, 2015,70(11):3134⁃3140. doi: 10.1093/jac/dkv246. |
[1] | Dou Jinfa, Wang Jianbo, Zhang Shuai, Li Jianguo, Liu Hongwei, Zhang Shoumin. Analysis of changes in disease status and their influencing factors in patients with moderate to severe plaque psoriasis receiving biologic therapy during the coronavirus disease 2019 pandemic: a single-center cross-sectional study [J]. Chinese Journal of Dermatology, 2024, 57(8): 739-742. |
[2] | Wei-Qi REN Ya-Ru ZOU Min PAN. Risk factors for secondary infection in patients with bullous pemphigoid [J]. Chinese Journal of Dermatology, 2024, 57(8): 770-772. |
[3] | Luo Li, Zhang Bona, Wu Wei, Tang Wenjing, Li Yuehua, Liu Xiaoli, Ma Yanan, Li Cuicui, Qi Mengyan, Sun Ni, Shi Qiong. Efficacy and safety of 308-nm excimer laser and 308-nm excimer lamp in the treatment of 194 children with vitiligo: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(8): 721-727. |
[4] | Xie yuanyuan, Liu Yuzhen, Zeng Rong, . Application of skin imaging techniques in acne vulgaris [J]. Chinese Journal of Dermatology, 2024, 57(8): 757-760. |
[5] | The Consensus Development Expert Group of Hematoporphyrin Monomethyl Ether-mediated Photodynamic Therapy for Treating Port-wine Stains. Expert consensus on hematoporphyrin monomethyl ether-mediated photodynamic therapy for treating port-wine stains (2024) [J]. Chinese Journal of Dermatology, 2024, 57(7): 581-589. |
[6] | Yang Aimin, Cheng Jiangwei, Huang Jiacheng, Cen Ying, Chen Junjie. Treatment of Merkel cell carcinoma [J]. Chinese Journal of Dermatology, 2024, 57(7): 665-667. |
[7] | Liu Qingfeng, Liu Lian, Diao Ping, Li Xiaoxue, Zhang Ting, Chen Haotian, Liu Xu, Jiang Xian. Diagnosis and treatment of port-wine stains-associated syndromes [J]. Chinese Journal of Dermatology, 2024, 57(7): 656-660. |
[8] | Chen Haotian, Liu Lian, Zhang Ting, Liu Qingfeng, Li Xiaoxue, Diao Ping, Jiang Xian. Port-wine stains: mechanisms underlying the development and progression [J]. Chinese Journal of Dermatology, 2024, 57(7): 661-664. |
[9] | Diao Ping, Han Chenglong, Liu Lian, Zhou Hui, Li Erlong, Jiang Xian. Efficacy and influencing factors of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of adult patients with port-wine stains: a retrospective study [J]. Chinese Journal of Dermatology, 2024, 57(7): 595-600. |
[10] | Zhang Sheng, Wang Xiuwei, Chen Jianyou, Deng Wei, Zhang Haihua, Zhang Gaolei, Liu Xiaoyan, Su Wei. Efficacy of hematoporphyrin monomethyl ether-mediated photodynamic therapy in the treatment of facial port-wine stains in 15 children with Sturge-Weber syndrome [J]. Chinese Journal of Dermatology, 2024, 57(7): 616-622. |
[11] | Jiang Xian, Liu Lian, Zhang Ting. Treatment of port-wine stains: current status and prospects [J]. Chinese Journal of Dermatology, 2024, 57(7): 590-594. |
[12] | aser Cosmetology Group, Medical Aesthetics and Cosmetology Branch of Chinese Medical Association, Skin Care Product and Material Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment, Laser Group, Cosmetic and Plastic Surgeon Branch of Chinese Medical Doctor Association, Cosmetic Laser Group, Chinese Society of Dermatology. Guidelines for the diagnosis and treatment of adverse skin reactions to cosmetics (2024 edition) [J]. Chinese Journal of Dermatology, 2024, 57(6): 485-492. |
[13] | Chinese Society of Dermatology, Dermatology and Venereology Branch of Chinese Association of Rehabilitation Medicine, China Dermatologist Association. Expert consensus on the clinical application of allergen-specific IgE tests in atopic dermatitis (2024 edition) [J]. Chinese Journal of Dermatology, 2024, 57(6): 493-502. |
[14] | Wang Chen, Xue Chenhong, Song Jinghui, Li Jianguo, Li Zhenlu, Zhang Shoumin, Li Ming, Wang Jianbo. Adalimumab for the treatment of three cases of Blau syndrome in a pedigree [J]. Chinese Journal of Dermatology, 2024, 57(6): 553-556. |
[15] | Sui Changlin, Chang Xiao, Zhao Qi, Zhu Wei. Psoriasis induced by anti-tumor targeted therapy and immunotherapy [J]. Chinese Journal of Dermatology, 2024, 57(6): 570-574. |
|